DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Sternberg CN, Hawkins R, Szczylik C et al.
Randomized, double-blind phase III study of Pazopanib in patients with advanced/metastatic renal cell carcinoma (MRCC): final overall survival (OS) results.
In: ESMO. ed. 2010. LBA22
We do not assume any responsibility for the contents of the web pages of other providers.